Evaluation of Hysterotomy Site After Open Fetal Surgery (Hysterotomy)

January 14, 2019 updated by: Laura Vricella, MD, St. Louis University

This study is to review how the uterus heals after having open fetal surgery. Open fetal surgery causes a scar perhaps two: one from the open fetal surgery and a second from delivery by cesarean section; rarely, the same area of your uterus was used for both open fetal surgery and delivery. From other studies of surgery performed on a uterus, some of the uterine scars do not heal well. This study's intervention uses sterile saline to spread open the inside of the uterus. The saline is slowly injected into the uterus using a catheter. An ultrasound called a sonohysterogram is performed to take pictures of the uterus, its inside and the walls of the uterus. In this way, the healed areas from the uterine surgery can be seen with ultrasound and evaluated. This is performed at least 6 months after delivery.

Primary Outcome:

Measure the depth of the scar and location of the scar 6 months or longer after delivery.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

This is an Investigator initiated, prospective study reviewing medical records and performing a sonohysterogram on non-pregnant women at 6 or more months after delivery of an infant who received open fetal repair.

An evaluation is completed at SSM Cardinal Glennon (CG), Fetal Care Institute (FCI) of a woman who has decided to have open fetal surgery to complete a fetal repair before the infant is born.

  • After open fetal surgery participant will be monitored and delivered appropriately.
  • After the infant is born investigators will review the mother's and infant's electronic health records and FCI database records
  • 6 months or more after delivery of an infant who has received open fetal repair the participant will go to Saint Louis University (SLU) Care for a sonohysterogram to evaluate the healing process.

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63104
        • SSM Cardinal Glennon Fetal Care Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • SSM Cardinal Glennon Fetal Care Institute evaluation
  • Received Open Fetal Surgery
  • Open fetal surgery of myelomeningocele: maternal age of >= 18 yrs. and <=50 yrs.
  • If a woman < 18 years old presented with a fetal tumor requiring open fetal repair, this would be done if deemed ethically sound by both CG and St. Mary's Health Center (SMHC) ethics committees. Given this, then the patient may qualify for this study. This is a RARE event.
  • Agree to travel to SSM St. Mary's in St. Louis for sonohysterogram 6 or more months after delivery.

Exclusion Criteria:

  • Presently pregnant
  • Hysterectomy after delivery
  • Menopause
  • Using IUD (Intrauterine Device) for birth control
  • There is no exclusion criteria for infants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: single-arm study
This single-arm study is described by women who have undergone prenatal fetal open (uterus was opened to perform a fetal intervention/surgery) surgery and cesarean section delivery. These women will undergo sonohysterogram.
The sonohysterogram can measure the size and depth of the uterine scar allowing better predictive values for future pregnancies.
Other Names:
  • ultrasound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean Hysterotomy Myometrial Thickness
Time Frame: Minimum of 6 months after delivery.
Average myometrium thickness surrounding niche is measured by measuring Average thickness of the myometrium toward the cervix and toward the fundus resulting in the average myometrium thickness surrounding the niche, measured by the sonohysterogram.
Minimum of 6 months after delivery.
Cesarean Hysterotomy Site Myometrial Percentage of Thinning at the Niche
Time Frame: Minimum of 6 months after delivery.

Average myometrium will be calculated, measured by the sonohysterogram. The myometrium will be measured caudad and cephalad of the niche and averaged ((Caudad side in mm + Cephalad side in mm)/2)=Average myometrium thickness The myometrium at niche will be measured (niche mm). Average myometrium-niche mm= niche thinning (mm).

Niche thinning / Average myometrium thickness= Percentage of thinning at the niche.

Ex:

Average thickness at niche: 0.5 mm Caudad myometrium thickness: 1.5 mm Cephalad myometrium thickness: 1.5 mm

1.5mm + 1.5mm= 3mm/ 2= 1.5mm (average Myometrium Thickness)

1.5mm- 0.5mm = 1.0 mm (Niche thinning)

0.5mm / 1.0 mm (% of thinning at the niche)

Minimum of 6 months after delivery.
Fetal Myelomeningocele Hysterotomy Site Myometrial Thickness
Time Frame: Minimum of 6 months after delivery.
Average myometrium thickness surrounding niche is measured by measuring average thickness of the myometrium to the right and left of the niche resulting in the average myometrium thickness surrounding the niche. This is measured by the sonohysterogram.
Minimum of 6 months after delivery.
Fetal Myelomeningocele Hysterotomy Site Myometrial Percentage of Thinning at the Niche
Time Frame: Minimum of 6 months after delivery.

Average myometrium will be calculated, measured by the sonohysterogram. The myometrium will be measure to the right and left of the niche and averaged ((Right side in mm + Left side in mm)/2)=Average myometrium thickness The myometrium at niche will be measured (niche mm). Average myometrium-niche mm= niche thinning (mm).

Niche thinning / Average myometrium thickness= Percentage of thinning at the niche.

Ex:

Average thickness at niche: 0.5 mm Right sided myometrium thickness: 1.5 mm Left sided myometrium thickness: 1.5 mm

1.5mm + 1.5mm= 3mm/ 2= 1.5mm (average Myometrium Thickness)

1.5mm- 0.5mm = 1.0 mm (Niche thinning)

0.5mm / 1.0 mm (% of thinning at the niche)

Minimum of 6 months after delivery.
Percent of Participants With/Without Dehiscence (>80% Thinning of the Myometrium) at the Niche
Time Frame: Minimum of 6 months after delivery.
Yes >80% of thinning of the myometrium at the niche or No < 80% of thinning of the myometrium at the niche of the hysterotomy measured by the sonohysterogram.
Minimum of 6 months after delivery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Laura Vricella, MD, St. Louis University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

December 20, 2017

Study Completion (Actual)

December 20, 2017

Study Registration Dates

First Submitted

June 3, 2015

First Submitted That Met QC Criteria

July 8, 2015

First Posted (Estimate)

July 9, 2015

Study Record Updates

Last Update Posted (Actual)

February 5, 2019

Last Update Submitted That Met QC Criteria

January 14, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Enrollment was below the target enrollment goals therefore statistical analysis was not completed.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Subscribe